
Thirty adult patients with CMML were evaluated to determine prognostic factors that might have an impact on conversion to acute leukemia and survival. Neither leukocyte count nor monocyte count correlated with survival. The median survival for all 30 cases was 41 months. Patients with less than 5% marrow blasts had a median survival of 60 months but those with 5-20% blasts had only a 9-month median survival.
Aged, 80 and over, Male, Chi-Square Distribution, Leukemia, Myelomonocytic, Chronic, Middle Aged, Prognosis, Monocytes, Survival Rate, Leukocyte Count, Bone Marrow, Humans, Regression Analysis, Female, Aged, Retrospective Studies
Aged, 80 and over, Male, Chi-Square Distribution, Leukemia, Myelomonocytic, Chronic, Middle Aged, Prognosis, Monocytes, Survival Rate, Leukocyte Count, Bone Marrow, Humans, Regression Analysis, Female, Aged, Retrospective Studies
| citations The total number of citations received by all articles of the researcher of interest. | 61 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 1% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
